Investors demand resignation of Mylan executives over pay packages
June 29, 2017Sales and Marketing Heather Bresch, Mylan, epipen
As confidence in Mylan continues to fall and share prices plummet after last year’s EpiPen pricing scandal and subsequent PR …
Novartis gains first-line approval for Zykadia in lung cancer
June 29, 2017Research and Development EMA, European Commission, NSCLC, Novartis
The European Commission has followed the EMA’s CHMP positive opinion by approving Novartis’ Zykadia for first-line treatment of patients with …
Investigational antibody boosts chemotherapy’s cancer-killing potential
June 29, 2017Research and Development CFH, Cancer, oncology, rituximab
A proof-of-concept study conducted at the Duke Cancer Institute (DCI) in North Carolina has shown that an investigational antibody has …
Enzyme able to untangle protein aggregates associated with Alzheimer’s
June 29, 2017Research and Development Alzheimer's, Parkinson's
There are currently no effective treatments for neurodegenerative disorders, such as Alzheimer’s and Parkinson’s disease. This is presently a pressing …
Researchers in world-first study on antibiotic use for sepsis
June 28, 2017Research and Development NHS, antibiotic, sepsis
The University of Warwick, alongside the University of Manchester, are launching a world-first study aimed at determining the length of …
Regenacy names new President and CEO
June 28, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Regenacy, appointment
Simon S Jones has been revealed as the new President and Chief Executive Officer of Regenacy Pharmaceuticals, a biopharma company …
Myeloma UK’s new CEO begins her role
June 28, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Myeloma UK
Myeloma UK, the only organisation in the UK dealing exclusively with myeloma, will have a new CEO in place from …
Lonza cleared to acquire Capsugel in $5.5 billion deal
June 28, 2017Manufacturing and Production, Research and Development, Sales and Marketing Capsugel, Lonza, acquisition
Swiss pharmaceutical manufacturer Lonza has announced that it has been cleared to proceed with its $5.5 billion acquisition of New …
Gold rods used to ‘break cancer’s legs’
June 28, 2017Research and Development Cancer, Georgia Tech, nanorods
A study emerging from Georgia Tech has found a new way of stopping metastasising cancer’s spread through the body. The …
MSD struck in second global cyber attack
June 28, 2017Medical Communications, Research and Development Cyber attack, MSD
Following the recent and heavily-publicised ransomware attack which hit the NHS in the UK and almost 100 other countries, the …
Revolutionary patch could offer alternative to flu injections
June 28, 2017Research and Development flu, flu vaccine, patch delivery
A patch developed by a team at the Georgia Institute of Technology alongside Emory University has found that it is …
FDA weighs in to improve generic competition
June 27, 2017Medical Communications, Sales and Marketing FDA, generic drugs, pricing debate
Since Scott Gottlieb was appointed Commissioner, the FDA has been on a marked push to tackle two areas: drug pricing …
Novo Nordisk’s diabetes drug recommended for expanded indication in Europe
June 27, 2017Research and Development, Sales and Marketing CHMP, EMA, EU, Novo Nordisk, Victoza
The EMA’s Committee for Medicinal Products for Human Use (CHMP) has given its recommendation to expand the indication of Novo …
New potential blockbuster RA treatment enters European market
June 27, 2017Sales and Marketing AbbVie, Humria, Kevzara, Regeneron, Sanofi
The world’s biggest selling drug, AbbVie’s Humira with $16 billion in sales last year, has a new rival in the …
Biogen appoint new Head of Global Therapeutic Operations
June 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen, Jean-Paul Kress
Biogen announced that Jean-Paul Kress has been appointed to the position of Executive Vice President and President, International, and Head …
UK launch of two Novartis biosimilars could cut NHS costs
June 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Erelzi, Novartis, Rixathon, Sandoz, biosimilar, etanercept, rituximab
Sandoz, a division of Swiss pharma giant Novartis, has revealed that two of its biosimilars – Rixathon (biosimilar rituximab) and …
Number of patients at risk from NHS mail mistake revealed
June 27, 2017Manufacturing and Production, Medical Communications Department of Health, Jeremy Hunt, NHS, NHS England
According to the patient records that have been examined so far, at least 1,700 may have been put at risk …
Duchenne drug made available to UK patients early
June 27, 2017Manufacturing and Production, Sales and Marketing Duchenne Muscular Dystrophy, Raxone
UK patients will be given access to Santhera Pharmaceutical’s Duchene Muscular Dystrophy (DMD) drug, Raxone (idebenone), through the Early Access …
The July/August 2017 issue of Pharmafocus is now live!
June 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus
The July/August edition of Pharmafocus is now available – click here to read online.
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
